DrugPatentWatch Database Preview

Polidocanol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for polidocanol and what is the scope of patent protection?

Polidocanol is the generic ingredient in two branded drugs marketed by Chemisch Fbrk Krsslr and Provensis, and is included in two NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Polidocanol has one hundred and two patent family members in thirty countries.

Two suppliers are listed for this compound.

Summary for polidocanol

International Patents:	102
US Patents:	5
Tradenames:	2
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	51
Clinical Trials:	23
Patent Applications:	4,555
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in polidocanol?	polidocanol excipients list
DailyMed Link:	polidocanol at DailyMed

Recent Clinical Trials for polidocanol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of the Republic, Uruguay	Phase 4
Centro Cardiovascular Universitario	Phase 4
Hospital de Clínicas Dr. Manuel Quintela	Phase 4

See all polidocanol clinical trials

Pharmacology for polidocanol

Drug Class	Sclerosing Agent
Mechanism of Action	Sclerosing Activity
Physiological Effect	Vascular Sclerosing Activity

US Patents and Regulatory Information for polidocanol

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes			Y
Chemisch Fbrk Krsslr	ASCLERA	polidocanol	SOLUTION;INTRAVENOUS	021201-001	Mar 30, 2010		RX	Yes	No
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes			Y	Y
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes			Y

Expired US Patents for polidocanol

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013

International Patents for polidocanol

Country	Patent Number	Estimated Expiration
Canada	2538172
Japan	2007511592
Germany	602004029802
Australia	2004290957